Boiron launches DXM-free cough product
This article was originally published in The Tan Sheet
Executive SummaryFollowing an FDA advisory committee meeting to evaluate dextromethorphan abuse, Boiron launches homeopathic, DXM-free cough syrup Chestal for adults. The firm launched Children's Chestal in 2008 when another FDA panel discussed the safety of active ingredients in other children's cough medicines. Chestal includes honey, which coats the throat, and a blend of homeopathic medicines that loosen chest congestion, the firm says. Like the children's version, the adult version is available in a 4.2-ounce bottle for $6.80, and a 8.45-ounce family size for $10.99. Newtown Square, Pa.-based Boiron also markets Oscillococcinum flu remedies and Arnicare pain relievers
You may also be interested in...
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.
Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza
The latest drug development news and highlights from our US FDA Performance Tracker.
Accelerated approval in epithelial sarcoma may de-risk the firm’s goals for approval of Tazverik in follicular lymphoma and other larger indications.